Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: An analysis of the NCIC CTG MA.5 and MA.12 clinical trials

J. F. Hilton, N. Bouganim, B. Dong, J. W. Chapman, A. Arnaout, F. O'Malley, K. A. Gelmon, R. Yerushalmi, M. N. Levine, V. H.C. Bramwell, T. J. Whelan, K. I. Pritchard, L. E. Shepherd, M. Clemons

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: An analysis of the NCIC CTG MA.5 and MA.12 clinical trials'. Together they form a unique fingerprint.

Medicine & Life Sciences